Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment
Abstract Background In January 2018, the Government of Ontario, Canada, initiated a universal pharmacare program (OHIP+) for all individuals aged 24 years and younger. In April 2019, the program was amended to cover only children and youth without private insurance. Because benzodiazepines are commo...
Saved in:
Main Authors: | Tony Antoniou (Author), Daniel McCormack (Author), Sophie Kitchen (Author), Kathleen Pajer (Author), William Gardner (Author), Yona Lunsky (Author), Melanie Penner (Author), Mina Tadrous (Author), Muhammad Mamdani (Author), David N. Juurlink (Author), Tara Gomes (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study
by: Tony Antoniou, et al.
Published: (2023) -
Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based study
by: Tony Antoniou, et al.
Published: (2023) -
The Risk of Ventricular Dysrhythmia or Sudden Death in Patients Receiving Serotonin Reuptake Inhibitors With Methadone: A Population-Based Study
by: Tony Antoniou, et al.
Published: (2022) -
Pharmacare 2019
by: Orlando, Valentina
Published: (2021) -
Understanding the Battle for Universal Pharmacare in Canada; Comment on "Universal Pharmacare in Canada"
by: Marc-André Gagnon
Published: (2021)